Programmed death ligand-1 may induce EMT by activating the TGF-β/Smad signaling pathway, and this process contributes to the primary resistance of EGFR-mutant NSCLC cells to TKIs (131, 132). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.